Literature DB >> 12460251

Lack of neuronal damage in atypical absence status epilepticus.

Yukiyoshi Shirasaka1.   

Abstract

PURPOSE: Whether status epilepticus of nonconvulsive epileptic seizures is harmful still remains controversial. To investigate this, the presence and/or extent of neuronal damage in patients with absence status epilepticus (ASE) and patients with complex partial status epilepticus (CPSE) was examined and compared.
METHODS: Neuron-specific enolase (NSE) in CSF was examined in the patients with ASE and compared with that of the patients having CPSE. Clinical aspects of these patients also were investigated.
RESULTS: CSF NSE levels in ASE patients were lower than those of CPSE patients and were considered as the normal values. No clinical symptoms indicated neuronal damage in the ASE patients.
CONCLUSIONS: This study suggests that ASE does not induce neuronal damage. Serum NSE is not always correlated to CSF NSE, and determination of serum NSE levels may be an inappropriate method of estimating neuronal damage in some cases of ASE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460251     DOI: 10.1046/j.1528-1157.2002.10502.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

1.  Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus.

Authors:  Matthew Ferguson; Matt T Bianchi; Raoul Sutter; Eric S Rosenthal; Sydney S Cash; Peter W Kaplan; M Brandon Westover
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

2.  Current and emerging treatments for absence seizures in young patients.

Authors:  Pascal Vrielynck
Journal:  Neuropsychiatr Dis Treat       Date:  2013-07-15       Impact factor: 2.570

3.  Pediatric Absence Status Epilepticus: Prolonged Altered Mental Status in an 8-Year-Old Boy.

Authors:  Scott J Adams; Melody Wong; Tahereh Haji; Shahmir Sohail; Salah Almubarak
Journal:  Case Rep Neurol Med       Date:  2016-11-16

Review 4.  Status Epilepticus and Beyond: A Clinical Review of Status Epilepticus and an Update on Current Management Strategies in Super-refractory Status Epilepticus.

Authors:  Roy Poblete; Gene Sung
Journal:  Korean J Crit Care Med       Date:  2017-05-31

Review 5.  A Theoretical Paradigm for Evaluating Risk-Benefit of Status Epilepticus Treatment.

Authors:  Edilberto Amorim; Chris M McGraw; M Brandon Westover
Journal:  J Clin Neurophysiol       Date:  2020-09       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.